Author:
Qi Qi,Geng Yawen,Sun Menghong,Chen Hao,Wang Peng,Chen Zhen
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference40 articles.
1. Cancer statistics, 2012.;Siegel;CA Cancer J Clin,2012
2. Pancreatic cancer.;Li;Lancet,2004
3. 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.;Burris;J Clin Oncol,1997
4. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL.;Wang;Mol Oncol,2013
5. Fibrinogen and fibrin.;Weisel;Adv Protein Chem,2005
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献